Healthcare / Health Information ServicesTokyo
$487.00
+3.00 (+0.62%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $828.0M · quality 63.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
49/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$33.7B
P/E
13.8x
↓EV/EBITDA
5.4x
↓ROE
12.0%
↑Gross Margin
50.2%
↑Debt/Equity
0.03
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+11.8%
FCF CAGR
-32.2%
FCF margin
2.7%
FCF / Net income
0.26x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $23.66B · net income $2.45B · FCF $627.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $23.66B | $23.66B | $24.84B | $20.36B | $16.92B |
| Net Income | $2.45B | $2.45B | $2.42B | $1.96B | $1.89B |
| EBITDA | $4.92B | $4.92B | $5.27B | $4.21B | $3.76B |
| EPS | 35.32 | 35.32 | 34.43 | 27.68 | 26.66 |
| Gross Margin | 50.2% | 50.2% | 54.6% | 48.7% | 48.9% |
| Operating Margin | 15.6% | 15.6% | 18.0% | 11.5% | 14.2% |
| Net Margin | 10.4% | 10.4% | 9.8% | 9.6% | 11.2% |
| Balance Sheet | |||||
| Debt/Equity | 0.03 | 0.03 | 0.07 | 0.13 | 0.01 |
| Current Ratio | 3.22 | 3.22 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $627.0M | $627.0M | $5.08B | $828.0M | $2.02B |
| Returns | |||||
| ROE | 12.0% | 12.0% | 11.8% | 9.6% | 9.7% |
| Valuation | |||||
| P/E | 13.78 | 13.78 | 22.71 | 25.83 | 30.91 |
| EV/EBITDA | 5.39 | 5.39 | 8.48 | 10.39 | 13.22 |
| P/B | 1.66 | 1.66 | 2.68 | 2.47 | 3.00 |
| Growth & Yield | |||||
| Revenue Growth | -4.7% | -4.7% | 22.0% | 20.3% | — |
| EPS Growth | 2.6% | 2.6% | 24.4% | 3.8% | — |
| Dividend Yield | 4.8% | 4.8% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
7.0%
EPS terminal req.
$43.21
Spread vs growth
-4.4%
5Y implied EPS CAGR
8.2%
EPS terminal req.
$52.29
Spread vs growth
-5.6%
10Y implied EPS CAGR
9.1%
EPS terminal req.
$84.21
Spread vs growth
-6.5%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-28.9%
Start / end P/E
21.3x → 13.8x
EPS bridge
34.43 → 35.32
Residual
-0.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.